THYROCARE TECHNOLOGIES Financial Statement Analysis
|
||
|
The Revenues of THYROCARE TECHNOLOGIES have increased by 20.61% YoY .
The Earnings Per Share (EPS) of THYROCARE TECHNOLOGIES has decreased by -40.01 % YoY. |
||
THYROCARE TECHNOLOGIES Last 5 Annual Financial Results
[BOM: 539871|NSE : THYROCARE]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹829 Cr | ₹687 Cr | ₹572 Cr | ₹527 Cr | ₹589 Cr |
| Expenses | ₹583 Cr | ₹497 Cr | ₹433 Cr | ₹404 Cr | ₹353 Cr |
| Operating Profit (Excl OI) | ₹246 Cr | ₹191 Cr | ₹139 Cr | ₹123 Cr | ₹236 Cr |
| Other Income | ₹34 Cr | ₹15 Cr | ₹9.37 Cr | ₹8.42 Cr | ₹29 Cr |
| Interest | ₹3.96 Cr | ₹3.74 Cr | ₹5.53 Cr | ₹4.83 Cr | ₹3.21 Cr |
| Depreciation | ₹59 Cr | ₹55 Cr | ₹47 Cr | ₹39 Cr | ₹34 Cr |
| Profit Before Tax | ₹213 Cr | ₹145 Cr | ₹96 Cr | ₹89 Cr | ₹228 Cr |
| Profit After Tax | ₹163 Cr | ₹91 Cr | ₹69 Cr | ₹64 Cr | ₹176 Cr |
| Consolidated Net Profit | ₹163 Cr | ₹91 Cr | ₹71 Cr | ₹66 Cr | ₹176 Cr |
| Earnings Per Share (Rs) | ₹10.27 | ₹17.12 | ₹13.42 | ₹12.47 | ₹33.28 |
| PAT Margin (%) | 19.64 | 13.20 | 12.15 | 12.22 | 29.91 |
| ROE(%) | 29.05 | 17.04 | 13.21 | 12.23 | 37.18 |
| ROCE(%) | 38.30 | 27.24 | 18.75 | 17.61 | 48.42 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 8,236.2 Cr |
| Revenue (TTM) | : | ₹ 829.0 Cr |
| Net Profit(TTM) | : | ₹ 161.5 Cr |
| EPS (TTM) | : | ₹ 10.1 |
| P/E (TTM) | : | 51.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| THYROCARE TECHNOLOGIES | -4.2% | 3.1% | 66.1% |
| APOLLO HOSPITALS ENTERPRISE | 1.1% | 4% | 22.3% |
| MAX HEALTHCARE INSTITUTE | 2.5% | 13% | -7% |
| FORTIS HEALTHCARE | -0.9% | -1.3% | 30.3% |
| ASTER DM HEALTHCARE | -5% | 1.4% | 34.6% |
| NARAYANA HRUDAYALAYA | 4.3% | 3.6% | 4.8% |
| GLOBAL HEALTH | 3.7% | 6.8% | 13.2% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -1.1% | 3.6% | 23.2% |
| DR LAL PATHLABS | 3.3% | 5.6% | 15.4% |
THYROCARE TECHNOLOGIES Revenues
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | 20.61 % |
| 5 Yr CAGR | 8.93 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹829 Cr | 20.61 | |
| Mar2025 | ₹687 Cr | 20.19 | |
| Mar2024 | ₹572 Cr | 8.58 | |
| Mar2023 | ₹527 Cr | -10.56 | |
| Mar2022 | ₹589 Cr | - | |
THYROCARE TECHNOLOGIES Operating Profit
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | 29.06 % |
| 5 Yr CAGR | 1.06 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹246 Cr | 29.06 | |
| Mar2025 | ₹191 Cr | 37.33 | |
| Mar2024 | ₹139 Cr | 13.25 | |
| Mar2023 | ₹123 Cr | -48.02 | |
| Mar2022 | ₹236 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 7.00 % |
| 5 Yr CAGR | -7.22 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 29.66% | 7.00 | |
| Mar2025 | 27.72% | 14.26 | |
| Mar2024 | 24.26% | 4.25 | |
| Mar2023 | 23.27% | -41.87 | |
| Mar2022 | 40.03% | - | |
THYROCARE TECHNOLOGIES Profit After Tax
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | 80.10 % |
| 5 Yr CAGR | -1.85 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹163 Cr | 80.10 | |
| Mar2025 | ₹91 Cr | 27.71 | |
| Mar2024 | ₹71 Cr | 7.62 | |
| Mar2023 | ₹66 Cr | -62.50 | |
| Mar2022 | ₹176 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 48.79 % |
| 5 Yr CAGR | -9.98 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 19.64 % | 48.79 | |
| Mar2025 | 13.2 % | 8.64 | |
| Mar2024 | 12.15 % | -0.57 | |
| Mar2023 | 12.22 % | -59.14 | |
| Mar2022 | 29.91 % | - | |
THYROCARE TECHNOLOGIES Earnings Per Share (EPS)
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | -40.01 % |
| 5 Yr CAGR | -25.47 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹10 | -40.01 | |
| Mar2025 | ₹17 | 27.57 | |
| Mar2024 | ₹13 | 7.62 | |
| Mar2023 | ₹12 | -62.53 | |
| Mar2022 | ₹33 | - | |
THYROCARE TECHNOLOGIES Return on Capital Employed (ROCE)
[BOM: 539871|NSE : THYROCARE]
| Y-o-Y | 40.60 % |
| 5 Yr CAGR | -5.69 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 38.3% | 40.60 | |
| Mar2025 | 27.24% | 45.28 | |
| Mar2024 | 18.75% | 6.47 | |
| Mar2023 | 17.61% | -63.63 | |
| Mar2022 | 48.42% | - | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Current Share Price | : | ₹517.4 |
| Current MarketCap | : | ₹ 8,236.2 Cr |
| Updated EOD on | : | Jun 25,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -4.2% |
3.1% |
66.1% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
THYROCARE TECHNOLOGIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 2.3% | 2.3% | 12.6% |
| BSE 1000 | -0.4% | 1.1% | 0.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 500 | 0.4% | 4.5% | NA |
| NIFTY MICROCAP 250 | 0.2% | 5.6% | 5.7% |
| NIFTY TOTAL MARKET | -0.4% | 1% | 1% |
You may also like the below Video Courses
FAQ about THYROCARE TECHNOLOGIES Financials
How the annual revenues of THYROCARE TECHNOLOGIES have changed ?
The Revenues of THYROCARE TECHNOLOGIES have increased by 20.61% YoY .
How the Earnings per Share (EPS) of THYROCARE TECHNOLOGIES have changed?
The Earnings Per Share (EPS) of THYROCARE TECHNOLOGIES has decreased by -40.01 % YoY .
Check out Intrinsic Value of Peers of THYROCARE TECHNOLOGIES
Compare Stock Analytics of Peers of THYROCARE TECHNOLOGIES
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
